Muscular dystrophy Skeletal muscle DUX4 Agrégats de PABPN1 Atrophy Myosin AAV vectors Gene therapy Myotube Geriatric assessment Pax7 Haploinsufficiency Regenerative medicine Muscle Arbovirus Biomarker Alzheimer's disease Alphavirus Fibrosis Mass spectrometry AChR antibodies Dysferlin 2-D PAGE Myoblasts Actin MND Myogenesis Muscle stem cells Omics AUTOPHAGY Aged Oculopharyngeal muscular dystrophy Regulatory T cells PABPN1 agregates Annexin A2 Muscle fibrosis Anti-fibrotic pharmacotherapies Cross-bridge kinetics Epigenetics OPMD Myoblast Autoimmune diseases Differentiation Satellite cells Sporadic ALS Amyotrophic Lateral Sclerosis Andermann syndrome Duchenne muscular dystrophy Aav-U7 Inflammation Myopathy APOPTOSIS RNA Sarcopenia Triplet expansion disease Exon-skipping Dysferlinopathy Transcriptomics DMD Cell therapy Metabolism Gene replacement Satellite cell Xenograft Functional genomics Human Neuromuscular junction NMJ ALS Secreted vesicles Akt Myositis Muscle strength Regeneration GENE Antisens oligonucleotides Muscle dystrophy MUTATIONS Aggregate FAPs Thérapie génique Dystrophin PABPN1 Adipose tissue Accelerometry Dystrophie musculaire oculopharyngée Antiserum Neuromuscular disease Lamins Effector T cells Calcium Nuclear envelope FSHD AAV Intercellular communication DNA methylation Pharyngeal muscle Anti-acetylcholine receptor antibodies Ageing Myopathies ARN